Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington's Disease.

BACKGROUND Huntington's disease (HD) is caused by an expanded (>35) CAG trinucleotide repeat in huntingtin (HTT). Age-at-onset of motor symptoms is inversely correlated with the size of the inherited CAG repeat, which expands further in brain regions due to somatic repeat instability. Our recent genetic investigation focusing on autosomal SNPs revealed that age-at-onset is also influenced by genetic variation at many loci, the majority of which encode genes involved in DNA maintenance/repair processes and repeat instability. OBJECTIVE We performed a complementary association analysis to determine whether variants in the X chromosome modify HD. METHODS We imputed SNPs on chromosome X for ∼9,000 HD subjects of European ancestry and performed an X chromosome-wide association study (XWAS) to test for association with age-at-onset corrected for inherited CAG repeat length. RESULTS In a mixed effects model XWAS analysis of all subjects (males and females), assuming random X-inactivation in females, no genome-wide significant onset modification signal was found. However, suggestive significant association signals were detected at Xq12 (top SNP, rs59098970; p-value, 1.4E-6), near moesin (MSN), in a region devoid of DNA maintenance genes. Additional suggestive signals not involving DNA repair genes were observed in male- and female-only analyses at other locations. CONCLUSION Although not genome-wide significant, potentially due to small effect size compared to the power of the current study, our data leave open the possibility of modification of HD by a non-DNA repair process. Our XWAS results are publicly available at the updated GEM EURO 9K website hosted at https://www.hdinhd.org/ for browsing, pathway analysis, and data download.

[1]  P. Holmans,et al.  Huntington’s Disease Pathogenesis: Two Sequential Components , 2021, Journal of Huntington's disease.

[2]  D. Monckton The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington’s Disease: A Historical Perspective , 2021, Journal of Huntington's disease.

[3]  Xiao-Qing Peng,et al.  The Autism‐Related lncRNA MSNP1AS Regulates Moesin Protein to Influence the RhoA, Rac1, and PI3K/Akt Pathways and Regulate the Structure and Survival of Neurons , 2020, Autism research : official journal of the International Society for Autism Research.

[4]  P. Holmans,et al.  Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects. , 2020, American journal of human genetics.

[5]  P. Holmans,et al.  A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes , 2019, EBioMedicine.

[6]  Jane S. Paulsen,et al.  CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset , 2019, Cell.

[7]  Nick C Fox,et al.  MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1 , 2019, Brain : a journal of neurology.

[8]  Wei Chen,et al.  Statistics for X‐chromosome associations , 2018, Genetic epidemiology.

[9]  L. Jones,et al.  The central role of DNA damage and repair in CAG repeat diseases , 2018, Disease Models & Mechanisms.

[10]  P. Holmans,et al.  A modifier of Huntington's disease onset at the MLH1 locus , 2017, Human molecular genetics.

[11]  D. Monckton,et al.  A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. , 2016, DNA repair.

[12]  P. Holmans,et al.  DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases , 2016, Annals of neurology.

[13]  Peter Holmans,et al.  The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease. , 2016, American journal of human genetics.

[14]  Jane S. Paulsen,et al.  Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease , 2015, Cell.

[15]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[16]  M. MacDonald,et al.  Genetic modifiers of Huntington's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[17]  John R Yates,et al.  Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease. , 2013, Chemistry & biology.

[18]  Edith T. Lopez,et al.  Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches , 2013, PLoS genetics.

[19]  Greg W. Clark,et al.  MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice , 2013, PLoS genetics.

[20]  Jane S. Paulsen,et al.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion , 2012, Neurology.

[21]  Audrey E Hendricks,et al.  Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. , 2009, Human molecular genetics.

[22]  Edith T. Lopez,et al.  Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes , 2009, Neurobiology of Disease.

[23]  B. Harper Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[24]  C. E. Pearson,et al.  Repeat instability: mechanisms of dynamic mutations , 2005, Nature Reviews Genetics.

[25]  G. Bates History of genetic disease: The molecular genetics of Huntington disease — a history , 2005, Nature Reviews Genetics.

[26]  Raju Kucherlapati,et al.  (CAG)n-hairpin DNA binds to Msh2–Msh3 and changes properties of mismatch recognition , 2005, Nature Structural &Molecular Biology.

[27]  L. Ingram,et al.  Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: implications for the mechanism of triplet repeat expansion. , 2004, Human molecular genetics.

[28]  Karen Marder,et al.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Trautmann,et al.  ERM proteins regulate cytoskeleton relaxation promoting T cell–APC conjugation , 2004, Nature Immunology.

[30]  D. Reinberg,et al.  Epigenetic Dynamics of Imprinted X Inactivation During Early Mouse Development , 2004, Science.

[31]  Jane S. Paulsen,et al.  A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. , 2003, American journal of human genetics.

[32]  M. MacDonald,et al.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease , 2003, American journal of medical genetics. Part A.

[33]  M. MacDonald,et al.  Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. , 2003, Human molecular genetics.

[34]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[35]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[36]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[37]  I. V. Kovtun,et al.  Features of trinucleotide repeat instability in vivo , 2008, Cell Research.